Cedars-Sinai Health Ventures backs cardiac data startup to curtail missed diagnoses

Cedars-Sinai Health Ventures, the Los Angeles-based health system’s venture capital arm, led a $6 million series A funding round for cardiac data company RhythmScience.

Advertisement

The startup analyzes data from tens of thousands of cardiology patients, from such health systems as University of Chicago Medicine and Houston Methodist, to create standardized data aimed at curtailing missed diagnoses and unnecessary hospitalizations. The platform also tracks cardiac implants, wearables and weight scales in one portal.

“We understand the need for effective cardiac data solutions that are purposefully built to meet the needs of patients and their cardiology teams,” said James Laur, managing director of Cedars-Sinai Health Ventures, in a March 28 news release. “We believe that our collaboration with RhythmScience will further our leadership in the cardiac data space and provide our physicians with the best tools possible to prioritize the health and safety of our patients.”

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.